Gabapentin Solution
Product Images NDC 0121-2134

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 0121-2134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clcr (Gaba Os 1)

An illustration showing a formula for calculating creatinine clearance (CLCr), which includes variables for age (years), weight (kg), serum creatinine (mg/dL), and an adjustment factor for female patients (0.85).*

FDA Label Image

Structure (Gaba Os 2)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino-methyl group and a carboxylic acid group.*

FDA Label Image

Figure 1 (Gaba Os 3)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day groups. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain score from 0 to 10. Two periods marked: a 4-week dose titration and a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Gaba Os 4)

A line graph depicting mean pain scores over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Gabapentin doses show reduced mean pain scores over time compared to placebo.*

FDA Label Image

Figure 3 (Gaba Os 5)

Bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing two studies. Study 1 shows placebo (PBO) at 12% and Gabapentin 3600 mg at 29%. Study 2 shows placebo at 14%, Gabapentin 1800 mg at 32%, and Gabapentin 2400 mg at 34%. Statistical significance is indicated with p values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gaba Os 6)

A scatter plot chart depicting percentage difference on the vertical axis versus daily dose of gabapentin (mg) on the horizontal axis. The chart includes data points from three studies labeled as Study a, Study b, and Study c, shown with different colored squares. The daily doses range from approximately 600 mg to 1800 mg, with percentage differences ranging from about 5% to 18%.*

FDA Label Image

Bottle Label Unflavored (Gaba Os 7)

Gabapentin Oral Solution 250 mg per 5 mL label from PAI Pharma. The label indicates a 470 mL bottle with instructions for pharmacists to dispense a medication guide. It includes storage information and dosage amount per 5 mL, plus distributor details for PAI Pharma, Greenville, SC.*

FDA Label Image

5ml Lidding Label (Gaba Os 8)

Gabapentin Oral Solution 250 mg per 5 mL label from PAI Holdings, LLC dba PAI Pharma. The circular label includes the product NDC code, delivery volume of 5 mL, storage instructions at 2°C to 8°C (36°F to 46°F), and notes that the package is not child-resistant. The label specifies Rx only and includes a barcode and distributor information from Greenville, SC.*

FDA Label Image

6 mL Lidding Label (Gaba Os 9)

Gabapentin Oral Solution label indicating a delivered volume of 6 mL containing 300 mg of gabapentin. The label includes storage instructions to refrigerate between 2°C to 8°C, states it is not child-resistant, and is distributed by PAI Pharma, Greenville, SC. The label also includes an NDC barcode and number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.